NBTK.DE vs. ARKG
NBTK.DE (Invesco Nasdaq Biotech UCITS ETF) and ARKG (ARK Genomic Revolution Multi-Sector ETF) are both Health & Biotech Equities funds. NBTK.DE is passively managed, while ARKG is actively managed. Over the past 5 years, NBTK.DE returned 5.63%/yr vs -13.79%/yr for ARKG. At a 0.50 correlation, their price movements are largely independent. NBTK.DE charges 0.40%/yr vs 0.75%/yr for ARKG.
Performance
NBTK.DE vs. ARKG - Performance Comparison
Loading charts...
Different Trading Currencies
NBTK.DE is traded in EUR, while ARKG is traded in USD. To make them comparable, the ARKG values have been converted to EUR using the latest available exchange rates.
Returns By Period
In the year-to-date period, NBTK.DE achieves a 4.27% return, which is significantly lower than ARKG's 26.63% return.
NBTK.DE
- 1D
- 2.92%
- 1M
- 1.60%
- YTD
- 4.27%
- 6M
- 3.10%
- 1Y
- 38.65%
- 3Y*
- 9.94%
- 5Y*
- 5.63%
- 10Y*
- —
ARKG
- 1D
- 6.78%
- 1M
- 22.61%
- YTD
- 26.63%
- 6M
- 14.00%
- 1Y
- 57.72%
- 3Y*
- -0.05%
- 5Y*
- -13.79%
- 10Y*
- 7.50%
NBTK.DE vs. ARKG - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
NBTK.DE Invesco Nasdaq Biotech UCITS ETF | 4.27% | 18.60% | 4.57% | 2.51% | -6.11% | 7.46% | 14.59% | 17.24% |
ARKG ARK Genomic Revolution Multi-Sector ETF | 26.63% | 8.44% | -23.50% | 12.74% | -51.05% | -28.98% | 157.29% | 18.40% |
Correlation
The correlation between NBTK.DE and ARKG is 0.47, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.47 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.50 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.49 |
Correlation (All Time) Calculated using the full available price history since Oct 22, 2019 | 0.50 |
The correlation between NBTK.DE and ARKG has been stable across timeframes, ranging from 0.47 to 0.50 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NBTK.DE vs. ARKG — Risk / Return Rank
NBTK.DE
ARKG
NBTK.DE vs. ARKG - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco Nasdaq Biotech UCITS ETF (NBTK.DE) and ARK Genomic Revolution Multi-Sector ETF (ARKG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| NBTK.DE | ARKG | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.59 | ||
| Sortino ratioReturn per unit of downside risk | +0.74 | ||
| Omega ratioGain probability vs. loss probability | 1.34 | 1.24 | +0.09 |
| Calmar ratioReturn relative to maximum drawdown | 6.16 | 2.26 | +3.90 |
| Martin ratioReturn relative to average drawdown | 17.06 | 5.20 | +11.86 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| NBTK.DE | ARKG | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.03 | 1.43 | +0.59 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.27 | -0.31 | +0.59 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.19 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.42 | 0.17 | +0.25 |
Drawdowns
NBTK.DE vs. ARKG - Drawdown Comparison
The maximum NBTK.DE drawdown since its inception was -30.99%, smaller than the maximum ARKG drawdown of -81.91%. Use the drawdown chart below to compare losses from any high point for NBTK.DE and ARKG.
Loading charts...
Drawdown Indicators
| NBTK.DE | ARKG | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -30.99% | -81.91% | +50.92% |
Max Drawdown (1Y)Largest decline over 1 year | -6.24% | -25.67% | +19.43% |
Max Drawdown (3Y)Largest decline over 3 years | -29.35% | -51.55% | +22.20% |
Max Drawdown (5Y)Largest decline over 5 years | -30.99% | -78.50% | +47.51% |
Max Drawdown (10Y)Largest decline over 10 years | — | -81.91% | — |
Current DrawdownCurrent decline from peak | -1.44% | -66.26% | +64.82% |
Average DrawdownAverage peak-to-trough decline | -10.62% | -35.26% | +24.64% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.26% | 11.14% | -8.88% |
Volatility
NBTK.DE vs. ARKG - Volatility Comparison
The current volatility for Invesco Nasdaq Biotech UCITS ETF (NBTK.DE) is 6.41%, while ARK Genomic Revolution Multi-Sector ETF (ARKG) has a volatility of 12.27%. This indicates that NBTK.DE experiences smaller price fluctuations and is considered to be less risky than ARKG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NBTK.DE | ARKG | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.41% | 12.27% | -5.86% |
Volatility (6M)Calculated over the trailing 6-month period | 14.11% | 28.43% | -14.32% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.00% | 40.56% | -21.56% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.30% | 44.39% | -24.09% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.05% | 40.64% | -18.59% |
NBTK.DE vs. ARKG - Expense Ratio Comparison
NBTK.DE has a 0.40% expense ratio, which is lower than ARKG's 0.75% expense ratio.
Dividends
NBTK.DE vs. ARKG - Dividend Comparison
Neither NBTK.DE nor ARKG has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
ARKG ARK Genomic Revolution Multi-Sector ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.62% | 0.85% | 3.14% | 0.82% | 1.34% |
NBTK.DE Invesco Nasdaq Biotech UCITS ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
NBTK.DE and ARKG have a correlation of 0.47, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, NBTK.DE is cheaper at 0.40% per year. The better choice depends on whether you care most about return, fees, risk, or income.
NBTK.DE is cheaper with a 0.40% expense ratio, compared with 0.75% for ARKG.
They also come from different issuers: Invesco and ARK. Their fees differ too: 0.40% for NBTK.DE and 0.75% for ARKG.
Find the right allocation for NBTK.DE and ARKG
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer